Hiroaki Nagashima

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair”.

Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2000

N/A

0.718DataRank · unranked

119 citations

Hiroaki Nagashima, Jianfang Ning, Mara V.A. Koerner, Hiroaki Wakimoto, Daniel P. Cahill +1 more

Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma

Cancer Cell(2024)10.1016/j.ccell.2024.03.008

N/A

0.614DataRank · unranked

59 citations

Simon Gritsch, Masashi Nomura, Alexander Jucht, Jérôme Fortin, Ramya Raviram +25 more

Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0226

N/A

0DataRank · unranked

101 citations

Christine K. Lee, Kensuke Tateishi, Fumi Higuchi, Megha Subramanian, Seamus Rafferty +5 more

Local Targeting of NAD+ Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma

Cancer Research(2020)10.1158/0008-5472.can-20-1094

N/A

0DataRank · unranked

52 citations

Ameya R. Kirtane, Juri Kiyokawa, Hiroaki Nagashima, Aaron Lopes, Zain A. Tirmizi +5 more

Sirtuin activation targets IDH-mutant tumors

Neuro-Oncology(2020)10.1093/neuonc/noaa180

N/A

0DataRank · unranked

31 citations

Alexandria L. Fink, Jack A Banagis, Hiroaki Nagashima, Megha Subramanian, Christine K. Lee +6 more

CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0562

N/A

0DataRank · unranked

23 citations

Lisa Melamed, Ethan A. Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa +5 more